Eden review

Eden's differentiator on sermorelin is the format: a sublingual dissolving tablet as well as an injection, which removes the daily-needle objection that stops a lot of people before they start. Take the convenience at face value and nothing more — the ODT route has no head-to-head outcome data showing it matches the injection, and the underlying product is compounded and not FDA-approved either way.

Eden is a consumer telehealth brand that offers compounded sermorelin in two formats: a standard subcutaneous injection (a 5 mL vial with a home injection kit) and a sublingual dissolving tablet (ODT) taken at night. Sermorelin is one line among many: Eden's main business is GLP-1 weight loss, including access to branded Ozempic, Wegovy, Zepbound and Mounjaro as well as compounded options, and it also sells NAD⁺ (injection, nasal spray and skin cream), GHK-Cu hair foam, glutathione, methylene blue, MIC+B12, women's hormone therapy, hair-loss and ED treatment. The positioning is deliberately mainstream — a clean consumer product experience rather than a clinic-style peptide menu of a dozen compounds.

You complete an online form and meet with a licensed provider 100% online (Eden advertises same-day doctor visits), then receive a prescription only if the provider finds treatment appropriate, with medication shipped free from a state-licensed pharmacy in its network. Eden advertises 24/7 provider messaging and regular check-ins afterward. It is a consumer-telehealth model rather than a clinical one: fast, low-friction and built for people who want a defined product, not a workup. The public sermorelin page does not clearly include baseline labs; ask the prescriber what testing and follow-up your treatment requires and what it costs.

The sermorelin injection page advertises medication from $126 for month one, plus required membership at $39 initially and $99 monthly thereafter. That puts the advertised first-month minimum at $165; the ongoing medication price is not published there. The homepage instead says visits, medication and shipping are included with no additional fees. Product fine print and membership terms still separate those charges, so obtain a written total for your chosen product. Cancel membership at least 48 hours before renewal; no partial-period refund is promised.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Both the injection and the sublingual ODT are compounding-pharmacy products, not branded FDA-approved drugs, and are not therapeutically equivalent to any branded drug. Two separate evidence gaps are worth keeping distinct here. The first applies to sermorelin generally: its effect on the growth-hormone axis is a real, well-described mechanism, but the long-term human outcome data stays thin. The second is specific to the ODT — peptides are, as a class, poorly absorbed when taken by mouth, Eden itself says the tablet has “a different absorption process” from the injection, and we have not seen controlled data establishing that a sublingual sermorelin achieves the same growth-hormone-axis effect as the injection. The needle-free format solves a real adherence problem; it has not been shown to solve it without cost. Individual results vary.